Target Ovarian Cancer is thrilled to announce that our guide Genetic testing and hereditary ovarian cancer has won a special award for patient information on screening at the 2017 British Medical Association (BMA) Patient Information Awards. Our information guide also came runner up in the award for information on ethical issues.
The guide was launched last year to provide key information to women and their families about genetics and ovarian cancer, how to find out more about it and what implications it has for a woman with ovarian cancer and family.
Katherine Pinder, Deputy Director of Services at Target Ovarian Cancer, said: “I am proud that the genetic testing and hereditary ovarian cancer guide has been highly commended at the BMA Patient Information Awards. Target Ovarian Cancer develops information with care and attention, ensuring that there is a need for it, that experts from across the ovarian cancer field are instrumental in helping write it, and, crucially, that women with ovarian cancer are involved at every stage of the process. We adhere to the NHS England Information Standard principles, so getting this award is recognition of the commitment we have to providing accurate, trustworthy information and support to women across the UK.”
The BMA judges said: "This resource deals with a complex and emotive subject matter very well, empowering women to make important decisions about their and their children's futures... The quotes and stories are a real strong point... The photos aren't stock images but are women with experience of ovarian cancer. This gives warmth and a personal feel... It's clearly been influenced by women who have been through testing and the feedback has been really positive."
Annwen Jones, Chief Executive of Target Ovarian Cancer, said: “With such a high number of ovarian cancers caused by genetic mutations, it is vital that women who have already been diagnosed with ovarian cancer can access support and find out more about hereditary ovarian cancer. Women who have been diagnosed with ovarian cancer have for a long time faced a lack of information on the BRCA gene and the implications of genetic testing."
Find out more
- Order or download the guide through our website or by calling 020 7923 5475
- For information and support on any aspect of ovarian cancer, contact our nurse-led Support Line on 020 7923 5475 or email@example.com
- Women who have ovarian cancer need more support and information. Donate today and help us get it to them